NGN CAPITAL
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.
NGN CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
2003-07-01
Status:
Active
Contact:
+1 212 972 0077
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta Google Font API LetsEncrypt Content Delivery Network Organization Schema Typekit LocalBusiness Schema Squarespace
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
SnowMark Corporation
SnowMark Corporation is a venture capital firm specializing in investments in technology, healthcare informatics, and real estate sectors.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-07-24 | Exosome Diagnostics | NGN Capital investment in Series C - Exosome Diagnostics | 30 M USD |
| 2016-01-07 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 16 M USD |
| 2015-09-02 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 17.6 M USD |
| 2014-03-11 | Exosome Diagnostics | NGN Capital investment in Series B - Exosome Diagnostics | 27 M USD |
| 2014-01-01 | PIN Pharma | NGN Capital investment in Series A - PIN Pharma | 6.75 M USD |
| 2013-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 37.4 M CHF |
| 2012-11-27 | Endosense | NGN Capital investment in Series C - Endosense | 40.3 M USD |
| 2012-07-23 | Cerapedics | NGN Capital investment in Series C - Cerapedics | 19 M USD |
| 2010-12-17 | Small Bone Innovations | NGN Capital investment in Series F - Small Bone Innovations | 15 M USD |
| 2010-07-20 | Artisan Pharma | NGN Capital investment in Series C - Artisan Pharma | 3 M USD |
More informations about "NGN Capital"
Team — NGN Capital LLC
John R. Costantino is a Senior Advisor to and formerly Managing General Partner of NGN Capital LLC, a series of healthcare focused venture funds totaling …See details»
About NGN Capital
NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage …See details»
Kenneth Abramowitz | Kenneth Abramowitz
Kenneth Abramowitz, a leading threat analyst and financial analyst, is Managing General Partner of NGN Capital and author of the critically-acclaimed book The Multifront War: Defending America From Political Islam, China, Russia, …See details»
NGN Capital - Crunchbase Investor Profile & Investments
Nov 28, 2012 NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including …See details»
NGN Capital - Contacts, Employees, Board Members, Advisors
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.See details»
NGN Capital LLC | AUM 13F
Track the AUM, funds, and holdings for NGN Capital LLC over time. View the latest funds and 13F holdings. Compare against similar firms.See details»
NGN Capital Profile: Members Invested • OpenSecrets
NGN Capital organization profile: No members of congress invested in NGN Capital in 2018.See details»
NGN CAPITAL - Company Information, Competitors, News & FAQs
Find useful insights on NGN CAPITAL’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at NGN CAPITAL.See details»
Follow Venture Capital to Big Gains in Biotech: Peter Johann
Jul 5, 2012 Peter Johann is a managing general partner at NGN Capital, a venture capital firm that invests in private and public biotech and medical device companies. In this exclusive …See details»
NGN Capital (Heidelberg) - life-sciences-europe.com
Life Sciences Business Intelligence Web Portal for European countriesSee details»
INVESTMENT PARTNERS - Next Gen Nutrition Investments
At Next Gen Investment Partners, we focus on impact investing in the disruptive Food & Beverage sector. The NGN team has over +80 years of combined experience and with our proprietary …See details»
Peter Johann – Ngn Capital LLC - privatefunddata.com
Peter Johann is an employee with Ngn Capital LLC, a venture capital company. Peter is Manager and has served as Manager since 01/01/2006. Peter Johann has an ownership stake in Ngn …See details»
Kenneth Abramowitz Full Bio — NGN Capital LLC
Kenneth S. Abramowitz is a co-founder and Managing General Partner of NGN Capital. He joined NGN Capital from The Carlyle Group in New York where he was Managing Director from 2001 …See details»
NGN BioMed Opportunity II: Fund Performance | PitchBook
Dec 31, 2010 General Information Description NGN BioMed Opportunity II is a 2008 vinatge venture capital fund managed by NGN Capital. The fund is located in Stamford, Connecticut, …See details»
James Cali - Next Gen Nutrition Investments
Jim joined NGN after a 34-year record of success in general management, sales & marketing, innovation, and organization development in food companies such as Cadbury, …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»
Trump Organization Sues Capital One for Closing Its Accounts
Mar 7, 2025 President Trump’s family business sued Capital One on Friday for “unjustifiably terminating” more than 300 of its bank accounts after the Jan. 6, 2021, attack on the Capitol, …See details»
Trump Organization accuses ‘woke’ Capital One of de-banking
Mar 10, 2025 The Trump Organization sued Capital One on Friday, alleging the bank closed its accounts over “woke” beliefs and political and social motivations. The Trump Organization and …See details»
Trump Company Sues ‘Woke’ Capital One for Canceling Accounts
Mar 7, 2025 President Donald Trump’s company sued Capital One Financial Corp., accusing it of illegally “de-banking” him for political reasons by abruptly canceling hundreds of accounts …See details»
NGN BioMed Opportunity II — NGN Capital LLC
NGN Capital led a $20 million PIPE financing of Resverlogix Corp., a publicly traded biotechnology company listed on the Toronto Stock Exchange (TSX). Resverlogix is a clinical …See details»